Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.
Financial Results:
Pfizer Ltd reported Revenues for Q4FY24 of ₹547.00 Crores down from ₹573.00 Crore year on year, a fall of 4.54%.
Total Expenses for Q4FY24 of ₹378.00 Crores down from ₹420.00 Crores year on year, a fall of 10.0%.
Consolidated Net Profit of ₹179.00 Crores up 37.69% from ₹130.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹39.10, up 37.97% from ₹28.34 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.